EM2D9, a monoclonal antibody against Integrin a5b1, has...

  • Main
  • 2020 / 3
  • EM2D9, a monoclonal antibody against Integrin a5b1, has...

EM2D9, a monoclonal antibody against Integrin a5b1, has potent antitumor activity on endometrial cancer in vitro and in vivo

Xu, Yinyan, Li, Yi, Pan, Jiahui, Kang, Xing, Zhang, Xu, Feng, Xinyi, Li, Shucheng, Li, Chengxi, Zhang, Jinku, Li, Chong, Wang, Guoqing
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Cancer Letters
DOI:
10.1016/j.canlet.2020.02.019
Date:
March, 2020
File:
PDF, 3.66 MB
2020
Conversion to is in progress
Conversion to is failed